Home
Flashcards
Preview
Econ Exam 2
Home
Get App
Take Quiz
Create
Cost minimization analysis
compare 2 or more alternatives are therapeutically equivalent
only costs are compared
areas where CMA may expand
mee too products
generic competition
changes in health care technology
analysis that presents costs and effects in a disaggregated format
cost-consequence analysis
Advantages of CCA
comprehensiveness
transparency for decision makers
approaches to conducting pharmacoeconomic studies
randomized controll trials
decision analysis
retrospective claims analysis
decision analysis trees
decision analysis decision tree
hypothetical decision tree
three state markov model
3 types of nodes in a decison tree
decision = square
chance = circle
end = triangle
11 questions to apprais study
perspective?
type?
competing alternatives?
were relevent costs properly identified?
were relevent costs properly measured?
were relevan costs properly valued?
instruments to measure QoL validated?
assumptions and limitations of study?
adjusted for time periods?
sensitivity analysis?
appropriate generalizations?
Total cost
FC + VC
do not vary when output changes
Fixed cost
overhead
sunk costs
vary directly with amount produced. increase as output increases
varied cost
cost of holding a capital good for a specific period of time depends on
depreciation and opportunity costs
extra or additional cost of producing one extra unit of output
marginal cost
additional output from the successive increas of one input will eventually deminish when other inputs are held constant
law of diminishing return
Marginal cost graph
falls at first then rises as output rises
u shaped curve
Minimum point
MC = AC
profit is highest at this point
when MC is below AC
it pulls AC down
when mc is above ac
it pulls ac up
factors that creat need for close monitering of value of pharmaceuticals
increased cost of drugs
increased number of treatment alternatives
growing demand for drugs
intro of high cost bio-tech drugs
where is pharmacoeconomics used? (7)
formulary
treatment guidlines
disease management programs
PA policies
step-therapy programs
benefit programs
health policies
framework that guides approach to a range of activitiesin the HC field
Health policy
Three levels of Health policy development
health policy
health care system
point of health care delivery
Author
Rx2013
ID
42240
Card Set
Econ Exam 2
Description
critical appraisal and application of pharmacoeconomics
Updated
2010-10-14T23:00:28Z
Show Answers
Home
Flashcards
Preview